Garretson T, Liu J, Li S, Scher G, Santos J, Hogan G
Nat Med. 2025; .
PMID: 40082696
DOI: 10.1038/s41591-025-03599-6.
Le Sage V, Werner B, Merrbach G, Petnuch S, OConnell A, Simmons H
Emerg Infect Dis. 2025; 31(3):477-487.
PMID: 40023796
PMC: 11878318.
DOI: 10.3201/eid3103.241485.
Sun X, Belser J, Li Z, Brock N, Pulit-Penaloza J, Kieran T
Emerg Infect Dis. 2025; 31(3):458-466.
PMID: 40023783
PMC: 11878296.
DOI: 10.3201/eid3103.241489.
Alvarez J, Boklund A, Dippel S, Dorea F, Figuerola J, Herskin M
EFSA J. 2025; 23(1):e9191.
PMID: 39882189
PMC: 11775931.
DOI: 10.2903/j.efsa.2025.9191.
Hawman D, Tipih T, Hodge E, Stone E, Warner N, McCarthy N
Nat Commun. 2025; 16(1):655.
PMID: 39809744
PMC: 11732985.
DOI: 10.1038/s41467-024-55546-7.
Computationally Optimized Hemagglutinin Proteins Adjuvanted with Infectimune Generate Broadly Protective Antibody Responses in Mice and Ferrets.
Allen J, Zhang X, Medina J, Thomas M, Lynch A, Nelson R
Vaccines (Basel). 2025; 12(12.
PMID: 39772026
PMC: 11679666.
DOI: 10.3390/vaccines12121364.
Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice.
Ma Y, Dong C, Kim J, Zhu W, Wei L, Wang Y
Vaccine. 2024; 46:126670.
PMID: 39731808
PMC: 11894583.
DOI: 10.1016/j.vaccine.2024.126670.
Targets of influenza human T-cell response are mostly conserved in H5N1.
Sidney J, Kim A, de Vries R, Peters B, Meade P, Krammer F
mBio. 2024; 16(2):e0347924.
PMID: 39714185
PMC: 11796400.
DOI: 10.1128/mbio.03479-24.
Differential antigenic imprinting effects between influenza H1N1 hemagglutinin and neuraminidase in a mouse model.
Lv H, Teo Q, Lee C, Liang W, Choi D, Mao K
J Virol. 2024; 99(1):e0169524.
PMID: 39636110
PMC: 11784018.
DOI: 10.1128/jvi.01695-24.
Spillover: Mechanisms, Genetic Barriers, and the Role of Reservoirs in Emerging Pathogens.
Pauciullo S, Zulian V, La Frazia S, Paci P, Garbuglia A
Microorganisms. 2024; 12(11).
PMID: 39597581
PMC: 11596118.
DOI: 10.3390/microorganisms12112191.
Pre-existing H1N1 immunity reduces severe disease with bovine H5N1 influenza virus.
Le Sage V, Werner B, Merrbach G, Petnuch S, OConnell A, Simmons H
bioRxiv. 2024; .
PMID: 39484442
PMC: 11527028.
DOI: 10.1101/2024.10.23.619881.
Vaccination against rapidly evolving pathogens and the entanglements of memory.
Cobey S
Nat Immunol. 2024; 25(11):2015-2023.
PMID: 39384979
DOI: 10.1038/s41590-024-01970-2.
The global H5N1 influenza panzootic in mammals.
Peacock T, Moncla L, Dudas G, VanInsberghe D, Sukhova K, Lloyd-Smith J
Nature. 2024; 637(8045):304-313.
PMID: 39317240
DOI: 10.1038/s41586-024-08054-z.
COBRA N2 NA vaccines induce protective immune responses against influenza viral infection.
Zhang X, Skarlupka A, Shi H, Ross T
Hum Vaccin Immunother. 2024; 20(1):2403175.
PMID: 39291424
PMC: 11657087.
DOI: 10.1080/21645515.2024.2403175.
Development of Influenza-Specific CD4 T Cell-Mediated Immunity in Children Following Inactivated Influenza Vaccination.
Shannon I, Huertas N, White C, Yang H, Nayak J
J Pediatric Infect Dis Soc. 2024; 13(10):505-512.
PMID: 39269455
PMC: 11534002.
DOI: 10.1093/jpids/piae095.
Influenza virus antibodies inhibit antigen-specific B cell responses in mice.
Goodwin E, Gibbs J, Yewdell J, Eisenlohr L, Hensley S
J Virol. 2024; 98(9):e0076624.
PMID: 39194245
PMC: 11406888.
DOI: 10.1128/jvi.00766-24.
Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses.
Maltseva M, Keeshan A, Cooper C, Langlois M
Hum Vaccin Immunother. 2024; 20(1):2384192.
PMID: 39149872
PMC: 11328881.
DOI: 10.1080/21645515.2024.2384192.
Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response.
Du P, Li N, Tang S, Zhou Z, Liu Z, Wang T
Heliyon. 2024; 10(14):e34492.
PMID: 39148990
PMC: 11324815.
DOI: 10.1016/j.heliyon.2024.e34492.
A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Tan S, Cebrik D, Plotnik D, Agostini M, Boundy K, Hebner C
Clin Infect Dis. 2024; 79(4):1054-1061.
PMID: 39036981
PMC: 11478579.
DOI: 10.1093/cid/ciae368.
Immunological imprinting and risks of influenza B virus infection.
Chow I, Wong S
Nat Immunol. 2024; 25(8):1319-1321.
PMID: 39030434
DOI: 10.1038/s41590-024-01906-w.